Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Clinical trial NCT03608033 · TERMINATED
Trial details
- NCT number
- NCT03608033
- Sponsor
- Omeros Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2024-01-12
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.